HHS Awards $25,958 for Remel Supplies to Support Sensititre Equipment Across Multiple Locations

Contract Overview

Contract Amount: $25,959 ($26.0K)

Contractor: Remel Inc.

Awarding Agency: Department of Health and Human Services

Start Date: 2026-04-07

End Date: 2026-06-02

Contract Duration: 56 days

Daily Burn Rate: $464/day

Competition Type: NOT COMPETED

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: VARIOUS REMEL SUPPLIES COMPATIBLE WITH SENSITITRE EQUIPMENT FOR MULTIPLE DELIVERY LOCATIONS

Place of Performance

Location: SILVER SPRING, MONTGOMERY County, MARYLAND, 20993

State: Maryland Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $25,958.58 to REMEL INC. for work described as: VARIOUS REMEL SUPPLIES COMPATIBLE WITH SENSITITRE EQUIPMENT FOR MULTIPLE DELIVERY LOCATIONS Key points: 1. The award focuses on essential diagnostic supplies, indicating a need for reliable testing capabilities. 2. Competition was not pursued, raising questions about potential price discovery and value for taxpayer dollars. 3. The risk of limited competition could lead to higher costs or reduced innovation. 4. The sector is In-Vitro Diagnostic Substance Manufacturing, a critical area for public health.

Value Assessment

Rating: questionable

The contract value is relatively small, making direct comparison difficult. However, the lack of competition suggests potential overpricing compared to what might be achieved through a competitive bidding process.

Cost Per Unit: N/A

Competition Analysis

Competition Level: sole-source

This contract was not competed, indicating a sole-source or limited competition approach. This limits price discovery and may not yield the best value for the government.

Taxpayer Impact: The lack of competition means taxpayers may not be receiving the most cost-effective solution for these essential supplies.

Public Impact

Ensures availability of critical diagnostic supplies for public health monitoring. Supports the operational needs of the Food and Drug Administration. Potential for increased costs due to lack of competitive bidding.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Lack of competition
Potential for overpricing
Limited vendor options

Positive Signals

Supports critical health infrastructure
Fixed price contract provides cost certainty

Sector Analysis

The In-Vitro Diagnostic Substance Manufacturing sector is vital for healthcare. Spending benchmarks for similar supplies can vary widely based on specific product types and quantities, but competitive procurement typically drives prices down.

Small Business Impact

There is no indication that small businesses were involved in this procurement. Further analysis would be needed to determine if opportunities were missed.

Oversight & Accountability

The award was a delivery order under an existing contract, suggesting some level of prior oversight. However, the lack of competition for this specific order warrants scrutiny.

Related Government Programs

In-Vitro Diagnostic Substance Manufacturing
Department of Health and Human Services Contracting
Food and Drug Administration Programs

Risk Flags

Lack of competition
Potential for price gouging
Supply chain dependency
Limited market research evident

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $25,958.58 to REMEL INC.. VARIOUS REMEL SUPPLIES COMPATIBLE WITH SENSITITRE EQUIPMENT FOR MULTIPLE DELIVERY LOCATIONS

Who is the contractor on this award?

The obligated recipient is REMEL INC..

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Food and Drug Administration).

What is the total obligated amount?

The obligated amount is $25,958.58.

What is the period of performance?

Start: 2026-04-07. End: 2026-06-02.

What is the justification for not competing this requirement, and what steps were taken to ensure fair and reasonable pricing?

The justification for not competing this requirement is not provided in the data. To ensure fair and reasonable pricing, the agency should have conducted market research to identify potential sources and negotiated the price based on historical data, commercial pricing, or other cost-effective methods. Without this information, it's difficult to assess the value obtained.

What is the risk associated with relying on a single source for these critical diagnostic supplies?

The primary risk is the potential for inflated prices due to the absence of competition. Additionally, reliance on a single source can lead to supply chain vulnerabilities if the vendor experiences production issues or goes out of business. This could disrupt critical diagnostic testing operations.

How effective is this procurement strategy in ensuring the government receives the best value for its investment in diagnostic supplies?

This procurement strategy is likely not effective in ensuring the best value. Sole-source or non-competed awards generally result in higher prices and less innovation compared to competitive processes. While the supplies are necessary, the lack of competition suggests that the government may be overpaying and missing opportunities for cost savings.

Industry Classification

NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › In-Vitro Diagnostic Substance Manufacturing

Product/Service Code: INSTRUMENTS AND LABORATORY EQPT

Competition & Pricing

Extent Competed: NOT COMPETED

Solicitation Procedures: ONLY ONE SOURCE

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Thermo Fisher Scientific Inc.

Address: 12076 SANTA FE TRAIL DR, LENEXA, KS, 66215

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations

Financial Breakdown

Contract Ceiling: $25,959

Exercised Options: $25,959

Current Obligation: $25,959

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: 75F40122D00010

IDV Type: IDC

Timeline